Literature DB >> 27098625

Analysis of Cerebrospinal Fluid and Serum CEA Concentration in Non-neoplastic Diseases.

Qiang Shi1, Chenglin Tian1, Xusheng Huang2, Chuanqiang Pu3.   

Abstract

BACKGROUND: Carcinoembryonic antigen (CEA) in cerebrospinal fluid (CSF) is important for the diagnosis of meningeal carcinomatosis. Its relationship with CSF and serum in non-neoplastic diseases may be beneficial for earlier diagnosis and treatment.
METHODS: CSF samples were obtained from 346 non-neoplastic inpatients. Among them, 238 pairs of CSF and serum were obtained and compared. The 97.5(th) percentile and maximum value of CSF CEA were obtained.
RESULTS: The 97.5(th) percentile and maximum value of CSF CEA concentration for overall participants were 0.529 and 2.340 µg/L, respectively. The ratio of CEA level (CSF/serum) was from 0.017 to 1. CSF CEA concentration was equal to the simultaneous serum concentration only in 0.84% (2/238) and no higher than simultaneous serum CEA concentration was found.
CONCLUSIONS: The value determined in this study of CSF CEA is significantly lower than that usually used in clinical practice. CSF CEA concentration higher than the simultaneous serum CEA concentration suggests abnormal intrathecal CEA secretion.
© 2016 by the Association of Clinical Scientists, Inc.

Entities:  

Keywords:  Carcinoembryonic antigen; cerebrospinal fluid; meningeal carcinomatosis; serum

Mesh:

Substances:

Year:  2016        PMID: 27098625

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  1 in total

1.  A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients.

Authors:  Yukari Ogawa; Takeshi Saraya; Akinari Noda; Nozomi Kurokawa; Sho Sakuma; Kaori Aso; Sunao Mikura; Miku Oda; Manabu Ishida; Kojiro Honda; Keitaro Nakamoto; Masaki Tamura; Saori Takata; Haruyuki Ishii; Hajime Takizawa
Journal:  Medicine (Baltimore)       Date:  2021-04-09       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.